Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by kensteron Aug 01, 2019 7:50am
77 Views
Post# 29982866

RE:RE:RE:RE:RE:RE:Is $120-$130 Million Possible?

RE:RE:RE:RE:RE:RE:Is $120-$130 Million Possible?What I don't get is how they got it for 50 mil
INVSTIGAT0R>I'll make it a little simpler for you since you're clearly not too bright. - We own CC Pharma. - CC Pharma makes roughly 400 million Canadian per year. - 400 million/4 = 100 million per quarter. - That supply deal is literally just transferring cannabis from one of the buildings we own to another building we own. Get it?
Bullboard Posts